Covered recipient · General Payments record
MICHAEL PAUL LOWE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$538.44
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.69 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $90.66 | 5 |
| Lilly USA, LLC | $71.86 | 4 |
| Phathom Pharmaceuticals, Inc. | $48.13 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.95 | 1 |
| Electromed, Inc. | $21.17 | 1 |
| Pharmacosmos Therapeutics Inc. | $15.58 | 1 |
| PFIZER INC. | $14.97 | 1 |
| ABIOMED | $13.96 | 1 |
| Exact Sciences Corporation | $13.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $13.96 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142283901 | CMS |
| Amgen Inc. | $22.51 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115883878 | CMS |
| Amgen Inc. | $19.77 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115883883 | CMS |
| Amgen Inc. | $14.29 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115883898 | CMS |
| Amgen Inc. | $14.29 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115883904 | CMS |
| Amgen Inc. | $19.80 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115883889 | CMS |
| Electromed, Inc. | $21.17 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137901384 | CMS |
| Exact Sciences Corporation | $13.41 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114763735 | CMS |
| Lilly USA, LLC | $18.35 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135189961 | CMS |
| Lilly USA, LLC | $20.13 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135222469 | CMS |
| Lilly USA, LLC | $19.66 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135222474 | CMS |
| Lilly USA, LLC | $13.72 | 09/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135242371 | CMS |
| Novartis Pharmaceuticals Corporation | $21.95 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087148238 | CMS |
| PFIZER INC. | $14.97 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131584563 | CMS |
| Pharmacosmos Therapeutics Inc. | $15.58 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154823671 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.96 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151090539 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.51 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151090541 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.66 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151090543 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.